T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Apogee Enterprises
APOG
$887M
| $40.6M | 0.01% |
940,020
-40,230
| -4% | -$1.76M |
|
902
Devon Energy
DVN
$48.7B
| $40.6M | 0.01% |
672,964
+24,810
| +4% | +$1.51M |
|
903
Employers Holdings
EIG
$867M
| $40.5M | 0.01% |
1,500,850
-142,170
| -9% | -$3.33M |
|
904
Graham Holdings Company
GHC
$5B
| $40.4M | 0.01% |
63,714
-36,212
| -36% | -$21.4M |
|
905
Waste Management
WM
$90B
| $40.4M | 0.01% |
744,121
+46,300
| +7% | +$2.46M |
|
|
CLC
906
DELISTED
Clarcor
CLC
| $40.3M | 0.01% |
609,727
+8,980
| +1% | +$582K |
|
907
Culp Inc
CULP
$44.4M
| $40.2M | 0.01% |
1,503,617
+8,800
| +0.6% | +$199K |
|
|
AMT.PRA
908
DELISTED
American Tower Corporation
AMT.PRA
| $40.2M | 0.01% |
389,690
-1,008
| -0.3% | -$109K |
|
|
TPH
909
DELISTED
Tri Pointe Homes
TPH
| $40.1M | 0.01% |
2,600,973
+1,178,993
| +83% | +$17.7M |
|
910
Mueller Water Products
MWA
$4.03B
| $40M | 0.01% |
4,061,717
+486,880
| +14% | +$4.66M |
|
911
Maximus
MMS
$2.88B
| $39.8M | 0.01% |
596,200
+28,200
| +5% | +$1.67M |
|
912
Royal Gold
RGLD
$19.2B
| $39.8M | 0.01% |
630,450
-321,147
| -34% | -$22.1M |
|
913
Washington Trust Bancorp
WASH
$765M
| $39.6M | 0.01% |
1,036,942
-111,794
| -10% | -$4.24M |
|
|
MSCC
914
DELISTED
Microsemi Corp
MSCC
| $39.6M | 0.01% |
1,117,400
+102,780
| +10% | +$3.18M |
|
915
AptarGroup
ATR
$8.41B
| $39.5M | 0.01% |
622,610
+162,950
| +35% | +$10.5M |
|
|
PPL
916
PPL Corp
PPL
$26.8B
| $39.5M | 0.01% |
1,259,869
-498,422
| -28% | -$16M |
|
917
Manitowoc
MTW
$737M
| $39.3M | 0.01% |
2,014,848
+5,928
| +0.3% | +$111K |
|
918
HEICO Corp Class A
HEI.A
$37.9B
| $39.3M | 0.01% |
1,937,817
+38,330
| +2% | +$737K |
|
|
CGI
919
DELISTED
Celadon Group Inc
CGI
| $39.2M | 0.01% |
1,440,900
-116,396
| -7% | -$2.89M |
|
920
Haverty Furniture Companies
HVT
$446M
| $39.2M | 0.01% |
1,573,940
-237,880
| -13% | -$5.77M |
|
921
Forestar Group
FOR
$1.49B
| $39M | 0.01% |
2,472,910
+498,790
| +25% | +$7.35M |
|
922
Bread Financial
BFH
$4.49B
| $38.9M | 0.01% |
164,614
+4,944
| +3% | +$1.13M |
|
923
Hercules Capital
HTGC
$3.15B
| $38.7M | 0.01% |
2,874,440
+5,640
| +0.2% | +$82.7K |
|
924
Gibraltar Industries
ROCK
$1.47B
| $38.6M | 0.01% |
2,349,405
+600
| +0% | +$9.28K |
|
925
Safety Insurance
SAFT
$1.52B
| $38.3M | 0.01% |
640,845
+161,480
| +34% | +$9.91M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.